IOM Report Urges Better Care and Support for Dying Children

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 9
Volume 11
Issue 9

WASHINGTON-Dying children and their families often fail to get consistent care and effective help to meet spiritual, physical, and emotional needs, according to a new report from the Institute of Medicine. In funding research on dying children and their families, the report concluded, the National Institutes of Health should begin priority studies to improve the treatment of pain and aspects of care affecting families.

WASHINGTON—Dying children and their families often fail to get consistent care and effective help to meet spiritual, physical, and emotional needs, according to a new report from the Institute of Medicine. In funding research on dying children and their families, the report concluded, the National Institutes of Health should begin priority studies to improve the treatment of pain and aspects of care affecting families.

The report was prepared by a 14-member committee chaired by Richard E. Behrman, MD, JD, University of California, San Francisco.

Insurance, the report said, is often a problem. Most elderly patients are covered by Medicare, but about 15% of children have no medical insurance. Many others are covered by a hodgepodge of private and public insurers, which puts added pressure on their families.

Moreover, complex and restrictive health insurance rules can interfere with the continuity of a child’s care. The panel recommended revising Medicaid and private insurance rules that bar providing life-prolonging therapies to patients receiving hospice care.

The report also cited frustration as a major problem for parents coordinating their children’s care. It suggested that hospitals, hospices, and others involved in the caregiving process work together to promote the flow of needed information. Procedures and protocols are also needed to establish accountability of care.

Another problem cited in the report was the lack of trained health care professionals knowledgeable about end-of-life care and techniques for dealing with bereavement. Even fewer professionals are ready to deal with the special needs of dying children and their families. 

Recent Videos
Immunotherapy-based combinations may elicit a synergistic effect that surpasses monotherapy outcomes among patients with muscle-invasive bladder cancer.
A new partnership agreement involving AI use may help spread radiotherapeutic standards from academic centers to more patients in community-based practices.
For example, you have a belt of certain diseases or genetic disorders that you come across, such as sickle cell disease or thalassemia, that are more prevalent in these areas.
Recent findings presented at ASTRO 2025 suggest an “exciting opportunity” to expand the role of radiation oncology in different non-malignant indications.
The 3 most likely directions of radiotherapy advancements come from new technology, combinations with immunotherapy, and the incorporation of particle therapy.
Talent shortages in the manufacturing and administration of cellular therapies are problems that must be addressed at the level of each country.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
4 experts in this video
Related Content